New Option Approved for Inherited Metabolic Disease That Affects the Brain

(MedPage Today) — The FDA approved sepiapterin (Sephience) for the treatment of children and adults with phenylketonuria (PKU), PTC Therapeutics announced.
The approval includes broad labeling for the treatment of hyperphenylalaninemia in adult…

Source link : https://www.medpagetoday.com/genetics/generalgenetics/116718

Author :

Publish date : 2025-07-29 16:33:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

New Option Approved for Inherited Metabolic Disease That Affects the Brain

Lead in Gasoline Tied to Cognitive Impairment

Unwelcome Data on GLP-1 Agonists; Growth Hormone Drug for Adults; Top Endo Hospitals

Related Posts

Alzheimer’s Med Continues to Deliver Benefit at 3 Years

Our brain doesn’t actually reorganise itself after an amputation

Vitamin D Deficiency Tied to Cataract Risk in Young Adults

Growth in Milk Banks Strengthens Neonatal Nutrition

Elevated Leukocyte Counts Signal Diabetes Risk in HIV

Urate Drops Modestly in Semaglutide Users With Diabetes

Alzheimer’s Med Continues to Deliver Benefit at 3 Years

Our brain doesn’t actually reorganise itself after an amputation

Vitamin D Deficiency Tied to Cataract Risk in Young Adults

Growth in Milk Banks Strengthens Neonatal Nutrition

Elevated Leukocyte Counts Signal Diabetes Risk in HIV

Urate Drops Modestly in Semaglutide Users With Diabetes

Europe’s New Front Line in Hepatitis Fight

At Least 600 CDC Employees Are Getting Final Termination Notices, Union Says

Categories

Archives